RESUMEN
Regeneration of alveolar bone is an essential step in restoring healthy function following tooth extraction. Growth of new bone in the healing extraction socket can be variable and often unpredictable when systemic comorbidities are present, leading to the need for additional therapeutic targets to accelerate the regenerative process. One such target is the TAM family (Tyro3, Axl, Mertk) of receptor tyrosine kinases. These proteins have been shown to help resolve inflammation and maintain bone homeostasis and thus may have therapeutic benefits in bone regeneration following extraction. Treatment of mice with a pan-TAM inhibitor (RXDX-106) led to accelerated alveolar bone fill following first molar extraction in a mouse model without changing immune infiltrate. Treatment of human alveolar bone mesenchymal stem cells with RXDX-106 upregulated Wnt signaling and primed the cells for osteogenic differentiation. Differentiation of human alveolar bone mesenchymal stem cells with osteogenic media and TAM-targeted inhibitor RXDX-106 (pan-TAM), ASP-2215 (Axl specific), or MRX-2843 (Mertk specific) showed enhanced mineralization with pan-TAM or Mertk-specific inhibitors and no change with Axl-specific inhibitor. First molar extractions in Mertk-/- mice had increased alveolar bone regeneration in the extraction socket relative to wild type controls 7 d postextraction. Flow cytometry of 7-d extraction sockets showed no difference in immune cell numbers between Mertk-/- and wild type mice. RNAseq of day 7 extraction sockets showed increased innate immune-related pathways and genes associated with bone differentiation in Mertk-/- mice. Together, these results indicate that TAM receptor signaling, specifically through Mertk, can be targeted to enhance bone regeneration after injury.
Asunto(s)
Tirosina Quinasa del Receptor Axl , Proteínas Proto-Oncogénicas , Humanos , Ratones , Animales , Tirosina Quinasa c-Mer/metabolismo , Proteínas Proto-Oncogénicas/genética , Osteogénesis , Extracción Dental , Alveolo DentalRESUMEN
Bacterial dysbiosis is associated with Crohn's disease (CD), a chronic intestinal inflammatory disorder thought to result from an abnormal immune response against intestinal bacteria in genetically susceptible individuals. However, it is unclear whether dysbiosis is a cause or consequence of intestinal inflammation and whether overall dysbiosis or specific bacteria trigger the disease. Here, we show that the combined deficiency of NOD2 and phagocyte NADPH oxidase, two CD susceptibility genes, triggers early-onset spontaneous TH1-type intestinal inflammation in mice with the pathological hallmarks of CD. Disease was induced by Mucispirillum schaedleri, a Gram-negative mucus-dwelling anaerobe. NOD2 and CYBB deficiencies led to marked accumulation of Mucispirillum, which was associated with impaired neutrophil recruitment and killing of the bacterium by luminal neutrophils. Maternal immunoglobulins against Mucispirillum protected mutant mice from disease during breastfeeding. Our results indicate that a specific intestinal microbe triggers CD-like disease in the presence of impaired clearance of the bacterium by innate immunity.
Asunto(s)
Bacterias/inmunología , Enfermedad de Crohn/inmunología , Disbiosis/inmunología , Interacciones Microbiota-Huesped/genética , Mucosa Intestinal/inmunología , Animales , Bacterias/patogenicidad , Enfermedad de Crohn/genética , Enfermedad de Crohn/microbiología , Modelos Animales de Enfermedad , Disbiosis/genética , Disbiosis/microbiología , Femenino , Interacciones Microbiota-Huesped/inmunología , Inmunidad Innata/genética , Inmunoglobulinas/inmunología , Mucosa Intestinal/microbiología , Masculino , Ratones , Ratones Noqueados , NADPH Oxidasa 2/genética , Infiltración Neutrófila , Neutrófilos/inmunología , Proteína Adaptadora de Señalización NOD2/genéticaRESUMEN
Apoptosis-associated speck-like protein containing a CARD (ASC) is an adaptor molecule that mediates apoptotic and inflammatory signals, and implicated in tumor suppression. However, the mechanism of ASC-mediated apoptosis has not been well elucidated. Here, we investigated the molecular mechanisms of ASC-mediated apoptosis in several cell lines using a caspase recruitment domain 12-Nod2 chimeric protein that transduces the signal from muramyl dipeptide into ASC-mediated apoptosis. Experiments using dominant-negative mutants, small-interfering RNAs and peptide inhibitors for caspases indicated that caspase-8 was generally required for ASC-mediated apoptosis, whereas a requirement for caspase-9 depended on the cell type. In addition, caspase-like apoptosis-regulatory protein (CLARP)/Fas-like inhibitor protein, a natural caspase-8 inhibitor, suppressed ASC-mediated apoptosis, and Clarp-/- mouse embryonic fibroblasts were highly sensitive to ASC-mediated apoptosis. Bax-deficient HCT116 cells were resistant to ASC-mediated apoptosis as reported previously, although we failed to observe colocalization of ASC and Bax in cells. Like Fas-ligand-induced apoptosis, the ASC-mediated apoptosis was inhibited by Bcl-2 and/or Bcl-XL in type-II but not type-I cell lines. Bid was cleaved upon ASC activation, and suppression of endogenous Bid expression using small-interfering RNAs in type-II cells reduced the ASC-mediated apoptosis. These results indicate that ASC, like death receptors, mediates two types of apoptosis depending on the cell type, in a manner involving caspase-8.
Asunto(s)
Apoptosis/fisiología , Proteína Proapoptótica que Interacciona Mediante Dominios BH3/fisiología , Proteínas del Citoesqueleto/fisiología , Animales , Secuencia de Bases , Proteínas Adaptadoras de Señalización CARD , Células COS , Línea Celular , Chlorocebus aethiops , Humanos , ARN Interferente PequeñoRESUMEN
The gut microbiota has diverse and essential roles in host metabolism, development of the immune system and as resistance to pathogen colonization. Perturbations of the gut microbiota, termed gut dysbiosis, are commonly observed in diseases involving inflammation in the gut, including inflammatory bowel disease, infection, colorectal cancer and food allergies. Importantly, the inflamed microenvironment in the gut is particularly conducive to blooms of Enterobacteriaceae, which acquire fitness benefits while other families of symbiotic bacteria succumb to environmental changes inflicted by inflammation. Here we summarize studies that examined factors in the inflamed gut that contribute to blooms of Enterobacterieaceae, and highlight potential approaches to restrict Enterobacterial blooms in treating diseases that are otherwise complicated by overgrowth of virulent Enterobacterial species in the gut.
Asunto(s)
Infecciones Bacterianas/inmunología , Disbiosis/inmunología , Enterobacteriaceae/inmunología , Microbioma Gastrointestinal/inmunología , Inflamación/inmunología , Animales , Microambiente Celular , Neoplasias Colorrectales/inmunología , Neoplasias Colorrectales/microbiología , Enterobacteriaceae/crecimiento & desarrollo , Hipersensibilidad a los Alimentos/inmunología , Hipersensibilidad a los Alimentos/microbiología , Humanos , Enfermedades Inflamatorias del Intestino/inmunología , Enfermedades Inflamatorias del Intestino/microbiología , VirulenciaRESUMEN
Periodontitis is a chronic infectious disease driven by dysbiosis, an imbalance between commensal bacteria and the host organism. Periodontitis is a leading cause of tooth loss in adults and occurs in about 50% of the US population. In addition to the clinical challenges associated with treating periodontitis, the progression and chronic nature of this disease seriously affect human health. Emerging evidence suggests that periodontitis is associated with mechanisms beyond bacteria-induced protein and tissue degradation. Here, we hypothesize that bacteria are able to induce epigenetic modifications in oral epithelial cells mediated by histone modifications. In this study, we found that dysbiosis in vivo led to epigenetic modifications, including acetylation of histones and downregulation of DNA methyltransferase 1. In addition, in vitro exposure of oral epithelial cells to lipopolysaccharides resulted in histone modifications, activation of transcriptional coactivators, such as p300/CBP, and accumulation of nuclear factor-κB (NF-κB). Given that oral epithelial cells are the first line of defense for the periodontium against bacteria, we also evaluated whether activation of pathogen recognition receptors induced histone modifications. We found that activation of the Toll-like receptors 1, 2, and 4 and the nucleotide-binding oligomerization domain protein 1 induced histone acetylation in oral epithelial cells. Our findings corroborate the emerging concept that epigenetic modifications play a role in the development of periodontitis.
Asunto(s)
Epigénesis Genética/genética , Histonas/genética , Periodontitis/genética , Acetilación , Pérdida de Hueso Alveolar/microbiología , Animales , Línea Celular , ADN (Citosina-5-)-Metiltransferasa 1 , ADN (Citosina-5-)-Metiltransferasas/análisis , Modelos Animales de Enfermedad , Disbiosis/genética , Células Epiteliales/metabolismo , Células Epiteliales/microbiología , Fusobacterium nucleatum/genética , Fusobacterium nucleatum/fisiología , Recesión Gingival/microbiología , Interacciones Huésped-Patógeno/genética , Humanos , Queratinocitos/metabolismo , Queratinocitos/microbiología , Lipopolisacáridos/farmacología , Ratones , Mucosa Bucal/citología , Mucosa Bucal/microbiología , FN-kappa B/análisis , Proteína Adaptadora de Señalización NOD1/análisis , Pérdida de la Inserción Periodontal/microbiología , Periodontitis/microbiología , Modificación Traduccional de las Proteínas/genética , Receptor Toll-Like 1/análisis , Receptor Toll-Like 2/análisis , Receptor Toll-Like 4/análisis , Factores de Transcripción p300-CBP/análisisRESUMEN
Nods, a growing family of proteins containing a nucleotide-binding oligomerization domain (NOD), are involved in the regulation of programmed cell death (PCD) and immune responses. Members of the family include Apaf-1, Ced-4, Nod1, Nod2, and the cytosolic products of plant disease resistance genes. The NOD module is homologous to the ATP-binding cassette (ABC) found in a large number of proteins with diverse biological function. The centrally located NOD promotes activation of effector molecules through self-association and induced proximity of binding partners. The C-terminal domain of Nods serves as a sensor for intracellular ligands, whereas the N-terminal domain mediates binding to dowstream effector molecules and activation of diverse signaling pathways. Thus, Nods activate, through the NOD module, diverse signaling pathways involved in the elimination of cells via PCD and the host defense against pathogens.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Apoptosis , Proteínas de Caenorhabditis elegans , Proteínas Portadoras/metabolismo , Proteínas Portadoras/fisiología , Péptidos y Proteínas de Señalización Intracelular , Nucleótidos/metabolismo , Animales , Factor Apoptótico 1 Activador de Proteasas , Proteínas de Unión al Calcio/metabolismo , Caspasas/metabolismo , Núcleo Celular/metabolismo , Proteínas del Helminto/metabolismo , Humanos , Modelos Biológicos , Familia de Multigenes , Proteína Adaptadora de Señalización NOD1 , Proteína Adaptadora de Señalización NOD2 , Unión Proteica , Estructura Terciaria de Proteína , Proteínas/metabolismoRESUMEN
Apoptosis, a morphologically defined form of physiological cell death, is implemented by a death machinery whose executionary arm is a family of cysteine proteases called caspases. These death proteases are part of a proteolytic caspase cascade that is activated by diverse apoptotic stimuli from outside and inside of the cell. The cell death machinery is evolutionarily conserved and composed of caspases and their regulatory components that include activators and repressors. These key components of the death machinery are linked to signaling pathways that are activated by either ligation of death receptors expressed at the cell surface or intracellular death signals. Caspases are normally present in the cell as proenzymes that require limited proteolysis for activation of enzymatic activity. Recent studies suggest that the basic mechanism of caspase activation is conserved in evolution. Binding of initiator caspase precursors to activator molecules appears to promote procaspase oligomerization and autoactivation. Enzymatic activation of initiator caspases leads to proteolytic activation of downstream (effector) caspases and cleavage of a number of vital proteins, resulting in the orderly demise and removal of the cell.
Asunto(s)
Apoptosis , Caspasas/fisiología , Animales , Grupo Citocromo c/fisiología , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Humanos , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Transducción de Señal/fisiología , Especificidad por SustratoRESUMEN
The gene structure of the human ATP synthase alpha subunit (hATP1) was determined by cloning and sequencing. This gene is approximately 14 kbp in length and contains 12 exons interrupted by 11 introns. Mapping of the clones of hATP1 and Southern blot analysis of the genomic gene showed that there were a single copy of bona fide hATP1 gene and two pseudogenes. Primer extension and S1 mapping analysis showed the presence of multiple transcription initiation sites of the hATP1 gene. No TATA box or CAAT box was found near the transcription initiation sites. Comparison with the bovine gene showed that the 5'-flanking region of the hATP1 gene has an unconserved guanine-cytosine (GC) rich region, including several binding motifs of transcriptional factors, such as Sp1, AP-2, and GCF. By functional assay of gene expression, the basal promoter activity was located near the GC rich region. Comparison of the 5'-upstream region of the hATP1 gene with those of the genes for bovine ATP synthase alpha, human beta, and human gamma subunits indicated three common sequences, suggesting that putative cis-elements coordinate the expressions of the three subunit genes for the ATP synthase. The enhancer activities derived from the 5'-deletion mutants of a hATP1-CAT chimeric gene were different in cell lines from four different human tissues, suggesting the existence of cell type-specific gene regulation.
Asunto(s)
ADN Mitocondrial/genética , Regulación Enzimológica de la Expresión Génica , ATPasas de Translocación de Protón/genética , Secuencia de Aminoácidos , Secuencia de Bases , Clonación Molecular , ADN Complementario/genética , Genoma Humano , Biblioteca Genómica , Humanos , Datos de Secuencia Molecular , Conformación Proteica , ATPasas de Translocación de Protón/biosíntesis , Proteínas Recombinantes de Fusión/biosíntesis , Secuencias Reguladoras de Ácidos Nucleicos , Mapeo Restrictivo , Análisis de Secuencia de ADN , Homología de Secuencia de Ácido Nucleico , Distribución Tisular , Transcripción GenéticaRESUMEN
The juvenile visceral steatosis (JVS) mouse is a novel mutant animal for studying systemic carnitine deficiency. The importance of the model has been pointed out in carnitine-deficient cardiac hypertrophy, since cardiomyopathy has been often improved after oral carnitine therapy in human systemic carnitine deficiency. To understand the effects of carnitine deficiency on gene expression in the heart, we tried to find the genes regulated by carnitine by means of a modified differential display procedure. Carnitine palmitoyltransferase I (CPT I) was one of the isolated genes. The level of CPT I gene expression in the ventricles of the JVS mice was at least three- to sixfold that of normal mice as judged by reverse transcription-polymerase chain reaction (RT-PCR). When the JVS mice were treated with carnitine, CPT I gene expression was repressed to the level of normal mice. Therefore, the increased expression of the CPT I gene was associated with carnitine deficiency.
Asunto(s)
Cardiomiopatías/enzimología , Carnitina O-Palmitoiltransferasa/genética , Carnitina/deficiencia , Carnitina/farmacología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Encéfalo/enzimología , Cardiomiopatías/patología , Carnitina/administración & dosificación , ADN Complementario/metabolismo , Modelos Animales de Enfermedad , Femenino , Amplificación de Genes , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Masculino , Ratones , Ratones Mutantes , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , ARN Mensajero/metabolismo , Ratas , Mapeo RestrictivoRESUMEN
An emerging concept is the tight relationship between dysbiosis (microbiota imbalance) and disease. The increase in knowledge about alterations in microbial communities that reside within the host has made a strong impact not only on dental science, but also on immunology and microbiology as well as on our understanding of several diseases. Periodontitis is a well-characterized human disease associated with dysbiosis, characterized by the accumulation of multiple bacteria that play individual and critical roles in bone loss around the teeth. Dysbiosis is largely dependent on cooperative and competitive interactions among oral microbes during the formation of the pathogenic biofilm community at gingival sites. Oral pathobionts play different and synergistic roles in periodontitis development, depending on their host-damaging and immunostimulatory activities. Host immune responses to oral pathobionts act as a double-edged sword not only by protecting the host against pathobionts, but also by promoting alveolar bone loss. Recent studies have begun to elucidate the roles of individual oral bacteria, including a new type of pathobionts that possess strong immunostimulatory activity, which is critical for alveolar bone loss. Better understanding of the roles of oral pathobionts is expected to lead to a better understanding of periodontitis disease and to the development of novel preventive and therapeutic approaches for the disease.
Asunto(s)
Interacciones Microbianas/fisiología , Periodontitis/microbiología , Pérdida de Hueso Alveolar/inmunología , Pérdida de Hueso Alveolar/microbiología , Biopelículas/crecimiento & desarrollo , Interacciones Huésped-Patógeno/inmunología , Humanos , Inmunomodulación/inmunología , Periodontitis/inmunologíaRESUMEN
Periodontitis is a polymicrobial oral infection characterized by the destruction of tooth-supporting structures that can be linked to systemic diseases such as cardiovascular disease, diabetes or rheumatoid arthritis. Porphyromonas gingivalis, a bacterium implicated in the etiology of periodontitis, has shown variation in inducing T-cell responses among different strains. Therefore, in this study we investigated the strain-specific immune response using a murine experimental model of periodontitis. Periodontitis was induced by P. gingivalis strains A7A1-28, W83 and W50, and later confirmed by the presence of P. gingivalis in the oral microflora and by alveolar bone resorption. Splenocytes were evaluated for gene expression, cellular proteins and cytokine expression. Dendritic cells were stimulated in vitro for T helper cell-cytokine profiling. Results showed that P. gingivalis had the ability to alter the systemic immune response after bacterial exposure. Strains W50 and W83 were shown to induce alveolar bone loss, whereas the A7A1-28 strain did not significantly promote bone resorption in mice. Splenocytes derived from mice infected with strains W50 and W83 induced expression of high levels of interleukin-4 (IL-4) but A7A1-28 stimulated increased IL-10. Stimulation of dendritic cells in vitro showed a similar pattern of cytokine expression of IL-12p40, IL-6 and transforming growth factor-ß among strains. A distinct systemic response in vivo was observed among different strains of P. gingivalis, with IL-10 associated with the least amount of alveolar bone loss. Evaluation of pathogen-driven systemic immune responses associated with periodontal disease pathogenesis may assist in defining how periodontitis may impact other diseases.
Asunto(s)
Infecciones por Bacteroidaceae/inmunología , Periodontitis/inmunología , Porphyromonas gingivalis/inmunología , Linfocitos T/inmunología , Pérdida de Hueso Alveolar/inmunología , Pérdida de Hueso Alveolar/microbiología , Animales , Citocinas/inmunología , Células Dendríticas/inmunología , Modelos Animales de Enfermedad , Citometría de Flujo , Regulación Bacteriana de la Expresión Génica/genética , Interleucina-10/inmunología , Subunidad p40 de la Interleucina-12/inmunología , Interleucina-4/inmunología , Interleucina-6/inmunología , Masculino , Ratones , Ratones Endogámicos DBA , Ratones Endogámicos , Periodontitis/microbiología , Porphyromonas gingivalis/clasificación , Bazo/inmunología , Bazo/patología , Linfocitos T Colaboradores-Inductores/inmunología , Factor de Crecimiento Transformador beta/inmunología , Microtomografía por Rayos XAsunto(s)
Proteínas de Drosophila , Drosophila melanogaster/genética , Genes de Insecto , Proteínas de Insectos/genética , Proteínas/genética , Secuencia de Aminoácidos , Animales , Apoptosis , Proteínas Reguladoras de la Apoptosis , Secuencia de Bases , Fragmentación del ADN , ADN Complementario , Desoxirribonucleasas/genética , Humanos , Ratones , Datos de Secuencia Molecular , Proteínas de Unión a Poli-ADP-Ribosa , Homología de Secuencia de AminoácidoRESUMEN
34 cases of familial exudative vitreoretinopathy were seen during a 40-month period ending April 1981. There were 30 cases from 11 families and 4 sporadic cases. The familial cases showed the mode of inheritance compatible with the autosomal-dominant inheritance. Ophthalmoscopy and super-wide panoramic fluorescein angiography revealed characteristic retinal vascular abnormalities in all cases, embracing supernumerous vascular branchings, arteriovenous shunt formation in the extreme periphery, generalized hyperpermeability of vessels and incomplete arteriovenous interdigitating pattern. Vitreoretinal adhesion was present in the peripheral temporal retina in all cases. An avascular zone wider than 1 disc diameter was noted in the majority of cases in the extreme temporal periphery. A V-shaped retinal degeneration was seen along the temporal meridian in 18 cases (48%). Retinal detachment was present in 19 eyes of 14 cases, and it was rhegmatogenous in 11 and traction-induced in 8 eyes. Retinal exudates and total posterior vitreous detachment was seen only occasionally.
Asunto(s)
Enfermedades de la Retina/genética , Vasos Retinianos/patología , Cuerpo Vítreo , Adulto , Niño , Oftalmopatías/diagnóstico , Oftalmopatías/genética , Femenino , Angiografía con Fluoresceína , Fondo de Ojo , Humanos , Masculino , Linaje , Enfermedades de la Retina/diagnósticoRESUMEN
Two types of auxin-binding sites (sites I and II) in membranes from maize (Zea mays L.) coleoptiles were characterized. Site I was a protein with a relative molecular mass of 21 000, and the distribution of site I protein on sucrose density gradient fractionation coincided with that of NADH-cytochrome-c reductase (EC 1.6.99.3), a marker enzyme of the endoplasmic reticulum. Immunoprecipitation and immunoblotting studies showed that the content of site I protein in maize coleoptiles was approx. 2 µg·(g FW)(-1). Site II occurred in higher-density fractions and also differed immunologically from site I. Site I was present at the early developmental stage of the coleoptile and increased only twice during coleoptile growth between day 2 and 4. Site II activity was low at the early stage and increased more substantially between day 3 and 4, a period of rapid growth of the coleoptile. Both sites decreased concurrently after day 4, followed by a reduction in the growth rate of the coleoptile. Coleoptiles with the outer epidermis removed showed a lower site I activity than intact coleoptiles, indicating that site I was concentrated in the outer epidermis. Site II, in contrast, remained constant after removal of the outer epidermis. The results indicate that site I is not a precursor of site II and that the two sites are involved in different cellular functions.
RESUMEN
We previously purified an auxin-binding protein (ABP) from the microsomal fraction of maize shoots (Zea mays L. cv. Golden Cross Bantam). In the present study cDNA clones derived from mRNAs encoding the ABP were isolated and sequenced. The nucleotide sequence of the 822-base-pair cDNA includes a 603-base-pair open reading frame. RNA blot hybridization analysis indicated a single mRNA species of approximately 1.0 kilobase. The predicted precursor of ABP is composed of 201 amino acid residues and has a molecular weight of 21,976. The NH2-terminal sequence of 38 residues is hydrophobic and may be a signal peptide for translocation of the ABP across the membrane of the endoplasmic reticulum. The mature ABP, composed of 163 residues with a molecular weight of 18,352, contains a potential N-glycosylation site (Asn-Thr-Thr), and the COOH-terminal tetrapeptide (Lys-Asp-Glu-Leu) may be a signal for retention of the ABP in the lumen of the endoplasmic reticulum.
Asunto(s)
Reguladores del Crecimiento de las Plantas , Proteínas de Plantas , Receptores de Superficie Celular/genética , Zea mays/genética , Secuencia de Aminoácidos , Secuencia de Bases , Clonación Molecular , ADN/genética , Retículo Endoplásmico/metabolismo , Datos de Secuencia Molecular , Peso Molecular , ARN Mensajero/genética , SolubilidadRESUMEN
Apaf-1 is an important apoptotic signaling molecule that can activate procaspase-9 in a cytochrome c/dATP-dependent fashion. Alternative splicing can create an NH(2)-terminal 11-amino acid insert between the caspase recruitment domain and ATPase domains or an additional COOH-terminal WD-40 repeat. Recently, several Apaf-1 isoforms have been identified in tumor cell lines, but their expression in tissues and ability to activate procaspase-9 remain poorly characterized. We performed analysis of normal tissue mRNAs to examine the relative expression of the Apaf-1 forms and identified Apaf-1XL, containing both the NH(2)-terminal and COOH-terminal inserts, as the major RNA form expressed in all tissues tested. We also identified another expressed isoform, Apaf-1LN, containing the NH(2)-terminal insert, but lacking the additional WD-40 repeat. Functional analysis of all identified Apaf-1 isoforms demonstrated that only those with the additional WD-40 repeat activated procaspase 9 in vitro in response to cytochrome c and dATP, while the NH(2)-terminal insert was not required for this activity. Consistent with this result, in vitro binding assays demonstrated that the additional WD-40 repeat was also required for binding of cytochrome c, subsequent Apaf-1 self-association, binding to procaspase-9, and formation of active Apaf-1 oligomers. These experiments demonstrate the expression of multiple Apaf-1 isoforms and show that only those containing the additional WD-40 repeat bind and activate procaspase-9 in response to cytochrome c and dATP.
Asunto(s)
Caspasas/metabolismo , Grupo Citocromo c/metabolismo , Precursores Enzimáticos/metabolismo , Proteínas del Helminto , Proteínas/metabolismo , Secuencias Repetitivas de Aminoácido , Adenosina Trifosfato/metabolismo , Empalme Alternativo , Apoptosis/fisiología , Factor Apoptótico 1 Activador de Proteasas , Caspasa 9 , Activación Enzimática , Humanos , Unión Proteica , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Proteínas/genética , Proteínas Recombinantes/metabolismoRESUMEN
We have identified and characterized ARC, apoptosis repressor with caspase recruitment domain (CARD). Sequence analysis revealed that ARC contains an N-terminal CARD fused to a C-terminal region rich in proline/glutamic acid residues. The CARD domain of ARC exhibited significant homology to the prodomains of apical caspases and the CARDs present in the cell death regulators Apaf-1 and RAIDD. Immunoprecipitation analysis revealed that ARC interacts with caspase-2, -8, and Caenorhabditis elegans CED-3, but not with caspase-1, -3, or -9. ARC inhibited apoptosis induced by caspase-8 and CED-3 but not that mediated by caspase-9. Further analysis showed that the enzymatic activity of caspase-8 was inhibited by ARC in 293T cells. Consistent with the inhibition of caspase-8, ARC attenuated apoptosis induced by FADD and TRADD and that triggered by stimulation of death receptors coupled to caspase-8, including CD95/Fas, tumor necrosis factor-R1, and TRAMP/DR3. Remarkably, the expression of human ARC was primarily restricted to skeletal muscle and cardiac tissue. Thus, ARC represents an inhibitor of apoptosis expressed in muscle that appears to selectively target caspases. Delivery of ARC by gene transfer or enhancement of its endogenous activity may provide a strategy for the treatment of diseases that are characterized by inappropriately increased cell death in muscle tissue.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Apoptosis , Caspasas , Cisteína Endopeptidasas/fisiología , Inhibidores de Cisteína Proteinasa/fisiología , Proteínas Musculares/fisiología , Músculo Esquelético/fisiología , Secuencia de Aminoácidos , Proteínas Reguladoras de la Apoptosis , Proteínas Portadoras/fisiología , Caspasa 8 , Caspasa 9 , Clonación Molecular , Proteína de Dominio de Muerte Asociada a Fas , Expresión Génica , Humanos , Datos de Secuencia Molecular , Unión Proteica , Proteínas/fisiología , Alineación de Secuencia , Factor 1 Asociado a Receptor de TNFRESUMEN
Programmed cell death is essential in organ development and tissue homeostasis and its deregulation is associated with the development of several diseases in mice and humans. The precise mechanisms that control cell death have not been elucidated fully, but it is well established that this form of cellular demise is regulated by a genetic program which is activated in the dying cell. Here we report the identification, cloning and characterization of harakiri, a novel gene that regulates apoptosis. The product of harakiri, Hrk, physically interacts with the death-repressor proteins Bcl-2 and Bcl-X(L), but not with death-promoting homologs, Bax or Bak. Hrk lacks conserved BH1 and BH2 regions and significant homology to Bcl-2 family members or any other protein, except for a stretch of eight amino acids that exhibits high homology with BH3 regions. Expression of Hrk induces cell death which is inhibited by Bcl-2 and Bcl-X(L). Deletion of 16 amino acids including the conserved BH3 region abolished the ability of Hrk to interact with Bcl-2 and Bcl-X(L) in mammalian cells. Moreover, the killing activity of this mutant form of Hrk (Hrk deltaBH3) was eliminated or dramatically reduced, suggesting that Hrk activates cell death at least in part by interacting with and inhibiting the protection afforded by Bcl-2 and Bcl-X(L). Because Hrk lacks conserved BH1 and BH2 domains that define Bcl-2 family members, we propose that Hrk and Bik/Nbk, another BH3-containing protein that activates apoptosis, represent a novel class of proteins that regulate apoptosis by interacting selectively with survival-promoting Bcl-2 and Bcl-X(L).